HC Wainwright Upgrades Arcus Biosciences (NYSE:RCUS) to Buy
HC Wainwright upgraded shares of Arcus Biosciences (NYSE:RCUS – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Wednesday, Marketbeat.com reports. The firm currently has $24.00 price target on the stock, up from their previous price target of $18.00. HC Wainwright also issued estimates for Arcus […]
HC Wainwright upgraded shares of Arcus Biosciences (NYSE:RCUS – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Wednesday, Marketbeat.com reports. The firm currently has $24.00 price target on the stock, up from their previous price target of $18.00. HC Wainwright also issued estimates for Arcus […]
